Company intelligence / Profile preview

Supremebeing

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Supremebeing is an early-stage biotechnology company focused on leveraging artificial intelligence and advanced biological simulations to accelerate drug discovery for aging-related diseases. The company aims to identify novel therapeutic targets and develop small molecule interventions that can modulate the biological processes of aging. By integrating high-throughput experimental data with computational models, Supremebeing seeks to create a more efficient path from target identification to clinical candidates. Their primary focus is on extending human healthspan and addressing the root causes of age-related decline.

Therapeutic areas: Other
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Supremebeing.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Supremebeing.

Explore the full profile